Developer docs
API playgroundTry for free, no card

Search company profiles

NXT Biomedical

Full company profile

uuid00041ix

Namestring
NXT Biomedical
Legal namestring
NXT Biomedical, LLC
Company typeenum
Private
Founded yearint
2018
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersIrvine, United States
HQ citystring
Irvine
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device incubator, biomedical startups, medtech investment, intellectual property development, cardiovascular technology
Industry2 codes
PRIMARYFSANAHAC
Corporate Venture Studios & Incubators (Build/launch ventures)
SECONDARYFSANAHAL
Corporate Deep Tech / R&D Commercialization CVC
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Device Incubator
Social media profiles1 record
Cost components3 values
Technology or R&D, Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

NXT Biomedical is a medical device incubator that invests in intellectual property and develops breakthrough biomedical technologies to spin out multiple startups over a five-year horizon. The incubator partners with Deerfield Management, committing $25 million over five years to fund cutting-edge medical technologies addressing unmet clinical needs, with the goal of launching 5 to 8 startups that bring clinically relevant medical devices to market. Each spun-out entity is designed to deliver technologies that improve patient outcomes and reduce healthcare system costs.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

NXT Biomedical is a biomedical technology incubator rather than a product company. It is structured as a platform for developing medical device startups, with a stated vision to invest $25 million over five years to create five to eight startups spun out of the incubator. Each startup is intended to bring clinically relevant medical technology to market. The incubator partners with Deerfield Management and is led by medtech pioneer Stanton Rowe. No specific named products, modules, or commercial offerings have been launched yet, as the company is in the early-stage feasibility and startup development phase.

Product and service1 record
1Medical Device Startup Incubation Program
CategoryTechnology Incubation Services
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medical device incubator founded by Josh Makower that creates and funds early-stage device companies addressing large unmet clinical needs; directly analogous business model to NXT, operating as a venture studio rather than a fund.

TypeBroad incumbent
Description

Large medtech incumbent where Stanton Rowe previously served as CSO; provides a natural acquisition channel and benchmark for the strategic exit lane that NXT's spin-outs would target, plus the corporate venture posture against which NXT competes for talent.

TypeBroad incumbent
Description

Diversified medical device incumbent with an active corporate development and venture function; comparable because NXT spin-outs could be evaluated for acquisition and Stryker's portfolio illustrates the type of strategic outcomes NXT's model targets.

TypeBroad incumbent
Description

Corporate venture and incubator arm of J&J, where Rowe previously led business development at JJIS; directly relevant as an incumbent-sponsored model that supports early-stage medtech startup formation and competes for both founders and technologies.

TypeDirect peer
Description

Life sciences-focused venture studio that incubates and develops medical device and therapeutic ventures from internal IP; matches NXT on the model of internal IP generation followed by spin-out of operating companies.

TypeBroad incumbent
Description

Healthcare-focused investment firm and NXT's named capital partner; not a direct competitor but the most thematically adjacent funder — meaningful for benchmarking capital availability, program economics, and downstream syndication in the medtech venture studio category.

7InSeal Medical
TypeEmerging player
Description

Early-stage medical device company on whose board Stanton Rowe serves as a Director; useful as a small, comparable operating company that illustrates the kind of venture a platform like NXT might produce or collaborate with.

TypeDirect peer
Description

Nonprofit medtech incubator that mentors physicians and engineers and spins out device startups; comparable in mission (developing breakthrough medical technologies and launching startups) and in operating as an incubator rather than a commercial product company.

TypeBroad incumbent
Description

One of the world's largest medical device companies; relevant as both a potential acquirer of NXT spin-outs and a competitor for sourcing IP and engineering talent, shaping the strategic landscape NXT operates within.

TypeDirect peer
Description

Medical device-focused venture studio that conceives, incubates, and spins out new medtech companies using a similar model to NXT Biomedical: small core team, multiple parallel programs targeting unmet clinical needs, and reliance on a network of serial entrepreneurs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NXT Biomedical

Medical Device Incubatornxtbiomedical.com

NXT Biomedical firmographics

Firmographics
Name
NXT Biomedical
Legal name
NXT Biomedical, LLC
Website
https://nxtbiomedical.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

NXT Biomedical industry classification

Industry
Product category
Medical Device Incubator
NAICS
Scientific Research and Development Services (5417)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYFSANAHAC
Corporate Venture Studios & Incubators (Build/launch ventures)
SECONDARYFSANAHAL
Corporate Deep Tech / R&D Commercialization CVC

Keywords

  • Medical device incubator
  • Biomedical startups
  • Medtech investment
  • Intellectual property development
  • Cardiovascular technology

Where NXT Biomedical is headquartered

Location

Headquarters

HQ city
Irvine
HQ country
United States
HQ region
North America

Offices1 record

Markets served

NXT Biomedical business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations

NXT Biomedical product offering

Product offering

Core offering

NXT Biomedical is a medical device incubator that invests in intellectual property and develops breakthrough biomedical technologies to spin out multiple startups over a five-year horizon. The incubator partners with Deerfield Management, committing $25 million over five years to fund cutting-edge medical technologies addressing unmet clinical needs, with the goal of launching 5 to 8 startups that bring clinically relevant medical devices to market. Each spun-out entity is designed to deliver technologies that improve patient outcomes and reduce healthcare system costs.

Product overview

NXT Biomedical is a biomedical technology incubator rather than a product company. It is structured as a platform for developing medical device startups, with a stated vision to invest $25 million over five years to create five to eight startups spun out of the incubator. Each startup is intended to bring clinically relevant medical technology to market. The incubator partners with Deerfield Management and is led by medtech pioneer Stanton Rowe. No specific named products, modules, or commercial offerings have been launched yet, as the company is in the early-stage feasibility and startup development phase.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Device Startup Incubation Program

Companies that use NXT Biomedical

Customer profile

Segments1 record

Ideal customer profiles2 records

NXT Biomedical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

NXT Biomedical partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

NXT Biomedical competitors and assessment

Company assessment

Direct peers

  • ExploraMed: Medical device incubator founded by Josh Makower that creates and funds early-stage device companies addressing large unmet clinical needs; directly analogous business model to NXT, operating as a venture studio rather than a fund.
  • InCube Labs: Life sciences-focused venture studio that incubates and develops medical device and therapeutic ventures from internal IP; matches NXT on the model of internal IP generation followed by spin-out of operating companies.
  • Fogarty Institute for Innovation: Nonprofit medtech incubator that mentors physicians and engineers and spins out device startups; comparable in mission (developing breakthrough medical technologies and launching startups) and in operating as an incubator rather than a commercial product company.
  • The Foundry: Medical device-focused venture studio that conceives, incubates, and spins out new medtech companies using a similar model to NXT Biomedical: small core team, multiple parallel programs targeting unmet clinical needs, and reliance on a network of serial entrepreneurs.

Broad incumbents

  • Edwards Lifesciences: Large medtech incumbent where Stanton Rowe previously served as CSO; provides a natural acquisition channel and benchmark for the strategic exit lane that NXT's spin-outs would target, plus the corporate venture posture against which NXT competes for talent.
  • Stryker: Diversified medical device incumbent with an active corporate development and venture function; comparable because NXT spin-outs could be evaluated for acquisition and Stryker's portfolio illustrates the type of strategic outcomes NXT's model targets.
  • Johnson & Johnson Innovation / JLABS: Corporate venture and incubator arm of J&J, where Rowe previously led business development at JJIS; directly relevant as an incumbent-sponsored model that supports early-stage medtech startup formation and competes for both founders and technologies.
  • Deerfield Management: Healthcare-focused investment firm and NXT's named capital partner; not a direct competitor but the most thematically adjacent funder — meaningful for benchmarking capital availability, program economics, and downstream syndication in the medtech venture studio category.
  • Medtronic: One of the world's largest medical device companies; relevant as both a potential acquirer of NXT spin-outs and a competitor for sourcing IP and engineering talent, shaping the strategic landscape NXT operates within.

Emerging players

  • InSeal Medical: Early-stage medical device company on whose board Stanton Rowe serves as a Director; useful as a small, comparable operating company that illustrates the kind of venture a platform like NXT might produce or collaborate with.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

NXT Biomedical social profiles

Digital presence

NXT Biomedical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NXT Biomedical leadership team

Management profile

Number of profiles

Profiles3 records

NXT Biomedical funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NXT Biomedical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NXT Biomedical

What does NXT Biomedical do?

NXT Biomedical is a medical device incubator that invests in intellectual property and develops breakthrough biomedical technologies to spin out multiple startups over a five-year horizon. The incubator partners with Deerfield Management, committing $25 million over five years to fund cutting-edge medical technologies addressing unmet clinical needs, with the goal of launching 5 to 8 startups that bring clinically relevant medical devices to market. Each spun-out entity is designed to deliver technologies that improve patient outcomes and reduce healthcare system costs.

Is NXT Biomedical a public or private company?

NXT Biomedical is a private company. It is classified as venture growth investor backed and is currently operating.

When was NXT Biomedical founded?

NXT Biomedical was founded in 2018. It employs 1 to 10 people.

Where is NXT Biomedical based?

NXT Biomedical is headquartered in Irvine, United States, in the North America region.

Who are NXT Biomedical's main competitors?

Direct peers on record are ExploraMed, InCube Labs, Fogarty Institute for Innovation and The Foundry. Broad incumbents are Edwards Lifesciences, Stryker, Johnson & Johnson Innovation / JLABS, Deerfield Management and Medtronic. InSeal Medical is listed as an emerging player.

Does NXT Biomedical have an API?

No public API is recorded for NXT Biomedical.

What industry is NXT Biomedical in?

NXT Biomedical's product category is Medical Device Incubator. Its primary akta.pro industry code is FSANAHAC, Corporate Venture Studios & Incubators (Build/launch ventures), with a secondary code of FSANAHAL, Corporate Deep Tech / R&D Commercialization CVC. Its NAICS code is 5417 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals